New program aims to identify lung cancers earlier that may otherwise go undetected

Nov. 11, 2022
New program from OSU.

A common imaging test used for injuries and illnesses could have a secondary and important benefit: capturing subtle, early signs of lung cancer.

While computed tomography (CT) scans can provide important information to diagnose illnesses and conditions, these imaging tests can also reveal other unrelated issues, known as “incidental” findings, that raise questions beyond what the physicians were originally looking for.

The new Lung Nodule Program at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) combines the benefits of automated natural language processing tools with a subspecialized treatment team to create a system for flagging and methodically evaluating incidental lung nodule findings to capture subtle signs of lung cancer.

According to the American Cancer Society, more people die annually of lung cancer than breast, colon, and prostate cancer combined – largely due to late-stage diagnosis. 

The Ohio State University release

ID 186155466 © Noipornpan | Dreamstime.com
dreamstime_xxl_186155466
ID 310201943 © Oleksandra Tsvid | Dreamstime.com
dreamstime_xxl_310201943
ID 161604768 © Kateryna Kon | Dreamstime.com
dreamstime_xxl_161604768
ID 335528788 © Prostockstudio | Dreamstime.com
dreamstime_xxl_335528788